查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球过敏诊断与治疗市场
市场调查报告书
商品编码
1761729

全球过敏诊断与治疗市场

Global Markets for Allergy Diagnostics and Treatments
出版日期: | 出版商: BCC Research | 英文 194 Pages | 订单完成后即时交付

价格

全球过敏诊断和治疗市场规模预计将从 2025 年的 678 亿美元增长到 2030 年底的 964 亿美元，预测期内（2025-2030 年）的复合年增长率为 7.3%。

预计北美市场将从2025年的397亿美元成长到2030年底的567亿美元，预测期间的复合年增长率为7.4%。预计亚太市场将从2025年的86亿美元成长到2030年底的129亿美元，预测期间的复合年增长率为8.6%。

本报告调查了全球过敏诊断和治疗药物市场，提供了全面的市场概述、市场影响因素和市场机会的分析、市场规模的趋势和预测、各个细分市场和地区的详细分析以及主要企业的概况。

目录

第一章执行摘要

  • 市场展望
  • 研究范围
  • 市场摘要
  • 市场动态与成长要素
  • 細項分析
  • 区域分析
  • 结论

第二章 市场概述

  • 概述
  • 宏观经济因素分析
  • 医疗费用上涨
  • 环境污染和气候变迁
  • 经济发展与都市化
  • 波特五力分析

第三章 市场动态

  • 市场动态
  • 市场驱动因素
  • 过敏症诊断和治疗的进展
  • 全球过敏病例增加
  • 市场限制
  • 缺乏熟练的医生
  • 过敏药物的副作用
  • 市场机会
  • 强大的过敏治疗产品线
  • 透过先进的生物标记分析实现个人化过敏管理

第四章 监管情况

  • 概述
  • 法律规范
  • 美国
  • 欧洲
  • 德国
  • 日本

第五章 新兴技术

  • 概述
  • 使用人工智慧进行过敏测试
  • 分子过敏的资料集管理
  • 管道分析
  • 专利分析
  • 主要发现

第六章市场区隔分析

  • 细分市场
  • 全球过敏诊断和治疗市场（按类型）
  • 关键要点
  • 诊断
  • 治疗
  • 全球过敏诊断和治疗药物市场（按过敏原）
  • 关键要点
  • 食物过敏原
  • 吸入性过敏原
  • 药物过敏原
  • 其他的
  • 全球过敏诊断和治疗市场（按药物类别）
  • 关键要点
  • 处方药
  • 非处方药
  • 全球过敏诊断和治疗市场（按给药途径）
  • 地理分布
  • 全球过敏诊断和治疗市场（按地区）
  • 关键要点
  • 北美洲
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 南美洲

第七章 竞争讯息

  • 关键要点
  • 全球过敏诊断与治疗市场：公司分析
    • 近期动态
  • 最新产品发布

8. 过敏诊断与治疗市场的永续性：ESG 视角

  • ESG：简介
  • ESG 在过敏诊断和治疗市场中的作用
  • ESG风险评估
  • 结论

第九章 附录

  • 调查方法
  • 来源
  • 简称
  • 公司简介
  • ABBVIE INC.
  • ALK
  • AMGEN INC.
  • ASTRAZENECA
  • BAYER AG
  • F. HOFFMANN-LA ROCHE LTD.
  • GSK PLC.
  • LILLY
  • NOVARTIS AG
  • PFIZER INC.
  • REVVITY
  • SANOFI
  • STALLERGENES GREER
  • THERMO FISHER SCIENTIFIC INC.
  • VIATRIS INC.
  • 新兴Start-Ups/市场颠覆者
Product Code: PHM026D

The global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual rate growth (CAGR) of 7.3% from 2025 through 2030.

The North American market for allergy diagnostics and treatment is projected to grow from $39.7 billion in 2025 to $56.7 billion by the end of 2030, at a CAGR of 7.4% from 2025 through 2030.

The Asia-Pacific market for allergy diagnostics and treatment is projected to grow from $8.6 billion in 2025 to $12.9 billion by the end of 2030, at a CAGR of 8.6% from 2025 through 2030.

Report Scope

This report will provide detailed information on allergy diagnostics and treatments. It analyzes the market trends, with the base year for the study being 2024. It provides estimates for 2025, and forecasts for 2025 through 2030, including the compound annual growth rate (CAGR) for the forecast period. It also analyzes regional markets. This report will highlight allergy diagnostics, current and future market potential of treatments, and a detailed competitive environment analysis. The report will cover regulatory scenarios, drivers, restraints, and opportunities. Also included will be market shares for key players.

The market is segmented into two major categories: diagnostics and treatments. Diagnostics include skin testing (prick, patch, intradermal) and blood testing (antibody). Treatments include antihistamines, sympathomimetics, decongestants and combinations, corticosteroids, leukotrienes, mast cell stabilizers, immunotherapy, and others. Immunotherapy is further segmented into subcutaneous administration, sublingual liquid solutions, and sublingual tablets. The treatments market is segmented into food, drug, inhaled, and others based on allergen type. Drug types are market segmented into prescription drug and over-the-counter (OTC).

The allergy diagnostics and treatment market has been segmented into North America, Europe, the Asia-Pacific, the Middle East and Africa (MEA), and South America. The detailed regional analysis will cover major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. For market estimates, data will be provided with 2024 as the base year.

Report Includes

  • 161 data tables and 54 additional tables
  • Analyses of the trends in global markets for allergy diagnostics, immunotherapy and treatments, with revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
  • Estimates of the size and revenue prospects for the global market, along with a market share analysis by type, diagnostic type, treatment type, allergen type, drug type, route of administration, and region
  • Facts and figures pertaining to the market dynamics, new developments in diagnostic testing, advances in treatments, new regulations, and the impact of macroeconomic factors
  • Insights derived from the Porter's Five Forces model, as well as global supply chain analyses
  • Evaluation of recent patent activity and key granted and published patents
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading biotech companies
  • Analysis of the industry structure, including companies' market shares, strategic alliances, M&A activity, venture fundings and investment outlook
  • Profiles of leading companies, including ALK-Abello A/S, Stallergenes Greer, GSK plc., AbbVie Inc., and AstraZeneca

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary
  • Market Dynamics and Growth Factors
  • Segmental Analysis
  • Regional Analysis
  • Conclusion

Chapter 2 Market Overview

  • Overview
  • Macroeconomic Factor Analysis
  • Increasing Healthcare Expenditure
  • Environmental Pollution and Climate Change
  • Economic Development and Urbanization
  • Porter's Five Forces Analysis in the Allergy Diagnostics and Treatment Market
  • Threat of New Entrants (Moderate)
  • Bargaining Power of Suppliers (Moderate)
  • Bargaining Power of Buyers (High)
  • Threat of Substitutes (High)
  • Industry Rivalry (High)

Chapter 3 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Advances in Allergy Diagnostics and Treatment
  • Increasing Cases of Allergies Worldwide
  • Market Restraints
  • Lack of Skilled Physicians
  • Side-effects of Allergy Medications
  • Market Opportunities
  • Robust Pipeline of Allergy Medications
  • Personalized Allergy Management via Advanced Biomarker Profiling

Chapter 4 Regulatory Landscape

  • Overview
  • Regulatory Framework
  • U.S.
  • Europe
  • Germany
  • Japan

Chapter 5 Emerging Technologies

  • Overview
  • AI-driven Allergy Testing
  • Datasets Management in Molecular Allergy
  • Pipeline Analysis
  • Patent Analysis
  • Key Findings

Chapter 6 Market Segmentation Analysis

  • Segmentation Breakdown
  • Global Allergy Diagnostics and Treatment Market, by Type
  • Key Takeaways
  • Diagnostics
  • Treatments
  • Global Allergy Diagnostics and Treatment Market, by Allergen Type
  • Key Takeaways
  • Food Allergens
  • Inhaled Allergens
  • Drug Allergens
  • Other Allergens
  • Global Allergy Diagnostics and Treatment Market, by Drug Type
  • Key Takeaways
  • Prescription Drugs
  • Over-the-Counter Drugs
  • Market for Drugs, by Route of Administration
  • Geographic Breakdown
  • Global Allergy Diagnostics and Treatment Market, by Region
  • Key Takeaways
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa (MEA)
  • South America

Chapter 7 Competitive Intelligence

  • Key Takeaways
  • Company Analysis of the Allergy Diagnostics and Treatment Market
    • Recent Developments
  • Recent Product Launches

Chapter 8 Sustainability in the Allergy Diagnostics and Treatment Market: ESG Perspective

  • Introduction to ESG
  • Role of ESG in the Allergy Diagnostics and Treatment Market
  • ESG Risk Ratings
  • Conclusion

Chapter 9 Appendix

  • Methodology
  • Sources
  • Abbreviations
  • Company Profiles
  • ABBVIE INC.
  • ALK
  • AMGEN INC.
  • ASTRAZENECA
  • BAYER AG
  • F. HOFFMANN-LA ROCHE LTD.
  • GSK PLC.
  • LILLY
  • NOVARTIS AG
  • PFIZER INC.
  • REVVITY
  • SANOFI
  • STALLERGENES GREER
  • THERMO FISHER SCIENTIFIC INC.
  • VIATRIS INC.
  • Emerging Start-ups/Market Disruptors

List of Tables

  • Summary Table : Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
  • Table 1 : Recent Clinical Drug Trials
  • Table 2 : Difference in the U.S. and European Regulatory Landscapes
  • Table 3 : Examples of Clinical Trials in Allergy Drug Development
  • Table 4 : Allergy Diagnostics and Treatments Patent Analysis, 2025
  • Table 5 : Global Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 6 : Global Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 7 : Global Market for Allergy Diagnostics, by Region, Through 2030
  • Table 8 : Global Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 9 : Global Market for Allergy Treatment, by Immunotherapy Type, Through 2030
  • Table 10 : Global Market for Other Allergy Treatments, by Region, Through 2030
  • Table 11 : Global Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 12 : Global Market for Food Allergen in Allergy Diagnostic and Treatment, by Region, Through 2030
  • Table 13 : Global Market for Inhaled Allergens in Allergy Diagnostics and Treatment, by Region, Through 2030
  • Table 14 : Global Market for Drug Allergens in Allergy Diagnostics and Treatment, by Region, Through 2030
  • Table 15 : Global Market for Other Allergens in Allergy Diagnostics and Treatment, by Region, Through 2030
  • Table 16 : Global Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 17 : Global Market for Prescription Drugs in Allergy Diagnostics and Treatment, by Region, Through 2030
  • Table 18 : Global Market for OTC Drugs in Allergy Diagnostics and Treatment, by Region, Through 2030
  • Table 19 : Advantages and Disadvantages of Drug Routes
  • Table 20 : Global Market for Allergy Drugs, by Route of Administration, Through 2030
  • Table 21 : Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
  • Table 22 : North American Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 23 : North American Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 24 : North American Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 25 : North American Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 26 : North American Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 27 : North American Market for Allergy Diagnostics and Treatment, by Country, Through 2030
  • Table 28 : U.S. Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 29 : U.S. Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 30 : U.S. Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 31 : U.S. Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 32 : U.S. Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 33 : Canadian Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 34 : Canadian Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 35 : Canadian Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 36 : Canadian Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 37 : Canadian Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 38 : Mexican Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 39 : Mexican Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 40 : Mexican Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 41 : Mexican Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 42 : Mexican Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 43 : European Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 44 : European Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 45 : European Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 46 : European Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 47 : European Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 48 : European Market for Allergy Diagnostics and Treatment, by Country, Through 2030
  • Table 49 : German Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 50 : German Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 51 : German Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 52 : German Market for Allergy Diagnostic and Treatment, by Allergen Type, Through 2030
  • Table 53 : German Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 54 : U.K. Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 55 : U.K. Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 56 : U.K. Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 57 : U.K. Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 58 : U.K. Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 59 : French Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 60 : French Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 61 : French Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 62 : French Market for Allergy Diagnostic and Treatment, by Allergen Type, Through 2030
  • Table 63 : French Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 64 : Italian Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 65 : Italian Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 66 : Italian Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 67 : Italian Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 68 : Italian Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 69 : Spanish Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 70 : Spanish Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 71 : Spanish Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 72 : Spanish Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 73 : Spanish Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 74 : Rest of Europe Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 75 : Rest of Europe Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 76 : Rest of Europe Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 77 : Rest of Europe Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 78 : Rest of Europe Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 79 : Asia-Pacific Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 80 : Asia-Pacific Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 81 : Asia-Pacific Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 82 : Asia-Pacific Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 83 : Asia-Pacific Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 84 : Asia-Pacific Market for Allergy Diagnostics and Treatment, by Country, Through 2030
  • Table 85 : Chinese Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 86 : Chinese Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 87 : Chinese Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 88 : Chinese Market for Allergy Diagnostic and Treatment, by Allergen Type, Through 2030
  • Table 89 : Chinese Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 90 : Japanese Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 91 : Japanese Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 92 : Japanese Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 93 : Japanese Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 94 : Japanese Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 95 : Indian Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 96 : Indian Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 97 : Indian Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 98 : Indian Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 99 : Indian Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 100 : South Korean Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 101 : South Korean Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 102 : South Korean Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 103 : South Korean Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 104 : South Korean Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 105 : Australian Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 106 : Australian Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 107 : Australian Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 108 : Australian Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 109 : Australian Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 110 : Rest of Asia-Pacific Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 111 : Rest of Asia-Pacific Market for Allergy Diagnostics, by Type, Through 2030
  • Table 112 : Rest of Asia-Pacific Market for Allergy Treatment, by Type, Through 2030
  • Table 113 : Rest of Asia-Pacific Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 114 : Rest of Asia-Pacific Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 115 : MEA Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 116 : MEA Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 117 : MEA Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 118 : MEA Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 119 : MEA Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 120 : MEA Market for Allergy Diagnostics and Treatment, by Sub-region, Through 2030
  • Table 121 : Middle East Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 122 : Middle East Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 123 : Middle East Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 124 : Middle East Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 125 : Middle East Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 126 : African Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 127 : African Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 128 : African Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 129 : African Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 130 : African Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 131 : South American Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 132 : South American Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 133 : South American Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 134 : South American Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 135 : South American Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 136 : South American Market for Allergy Diagnostics and Treatment, by Country, Through 2030
  • Table 137 : Brazilian Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 138 : Brazilian Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 139 : Brazilian Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 140 : Brazilian Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 141 : Brazilian Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 142 : Argentine Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 143 : Argentine Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 144 : Argentine Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 145 : Argentine Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 146 : Argentine Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 147 : Rest of South America Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 148 : Rest of South America Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 149 : Rest of South America Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 150 : Rest of South America Market for Allergy Diagnostics and Treatment, by Allergen Type, Through 2030
  • Table 151 : Rest of South America Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
  • Table 152 : Leading Companies, 2024
  • Table 153 : Recent Developments in the Global Allergy Diagnostics and Treatment Market, 2022-2024
  • Table 154 : Product Launches in Allergy Diagnostics and Treatment Market, 2022-2025
  • Table 155 : ESG Risk Rankings for Allergy Diagnostic and Treatment Market Companies, 2025*
  • Table 156 : Report Information Sources
  • Table 157 : Abbreviations Used in the Allergy Diagnostics and Treatment Market
  • Table 158 : AbbVie Inc.: Company Snapshot
  • Table 159 : AbbVie Inc.: Financial Performance, FY 2023 and 2024
  • Table 160 : AbbVie Inc.: Product Portfolio
  • Table 161 : AbbVie Inc.: News/Key Developments, 2025
  • Table 162 : ALK: Company Snapshot
  • Table 163 : ALK: Financial Performance, FY 2023 and 2024
  • Table 164 : ALK: Product Portfolio
  • Table 165 : ALK: News/Key Developments, 2025
  • Table 166 : Amgen Inc.: Company Snapshot
  • Table 167 : Amgen Inc.: Financial Performance, FY 2023 and 2024
  • Table 168 : Amgen Inc.: Product Portfolio
  • Table 169 : Amgen Inc.: News/Key Developments, 2023
  • Table 170 : AstraZeneca: Company Snapshot
  • Table 171 : AstraZeneca: Financial Performance, FY 2023 and 2024
  • Table 172 : AstraZeneca: Product Portfolio
  • Table 173 : AstraZeneca: News/Recent Developments, 2023
  • Table 174 : Bayer AG: Company Snapshot
  • Table 175 : Bayer AG: Financial Performance, FY 2023 and 2024
  • Table 176 : Bayer AG: Product Portfolio
  • Table 177 : Bayer AG: News/Key Development, 2022
  • Table 178 : F. Hoffmann-La Roche Ltd.: Company Snapshot
  • Table 179 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
  • Table 180 : F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Table 181 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2024 and 2025
  • Table 182 : GSK plc.: Company Snapshot
  • Table 183 : GSK plc.: Financial Performance, FY 2023 and 2024
  • Table 184 : GSK plc.: Product Portfolio
  • Table 185 : GSK plc.: News/Key Developments, 2024
  • Table 186 : Lilly: Company Snapshot
  • Table 187 : Lilly: Financial Performance, FY 2023 and 2024
  • Table 188 : Lilly: Product Portfolio
  • Table 189 : Lilly: News/Key Developments, 2024
  • Table 190 : Novartis AG: Company Snapshot
  • Table 191 : Novartis AG: Financial Performance, FY 2023 and 2024
  • Table 192 : Novartis AG: Product Portfolio
  • Table 193 : Novartis AG: News/Key Developments 2024
  • Table 194 : Pfizer Inc.: Company Snapshot
  • Table 195 : Pfizer Inc.: Financial Performance, FY 2023 and 2024
  • Table 196 : Pfizer Inc.: Product Portfolio
  • Table 197 : Pfizer Inc.: News/Key Developments, 2022 and 2023
  • Table 198 : Revvity: Company Snapshot
  • Table 199 : Revvity: Financial Performance, FY 2023 and 2024
  • Table 200 : Revvity: Product Portfolio
  • Table 201 : Sanofi: Company Snapshot
  • Table 202 : Sanofi: Financial Performance, FY 2023 and 2024
  • Table 203 : Sanofi: Product Portfolio
  • Table 204 : Stallergenes Greer: Company Snapshot
  • Table 205 : Stallergenes Greer: Product Portfolio
  • Table 206 : Stallergenes Greer: News/Key Developments, 2024 and 2025
  • Table 207 : Thermo Fisher Scientific Inc.: Company Snapshot
  • Table 208 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
  • Table 209 : Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 210 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023
  • Table 211 : Viatris Inc.: Company Snapshot
  • Table 212 : Viatris Inc.: Financial Performance, FY 2023 and 2024
  • Table 213 : Viatris Inc.: Product Portfolio
  • Table 214 : List of Few Emerging Startups

List of Figures

  • Summary Figure : Global Market Shares of Allergy Diagnostic and Treatments, by Region, 2024
  • Figure 1 : Porter's Five Forces Analysis of the Allergy Diagnostic and Treatment Market
  • Figure 2 : Market Dynamics for Allergy Diagnostics and Treatment
  • Figure 3 : Global Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
  • Figure 4 : Global Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
  • Figure 5 : Global Market Shares of Allergy Diagnostics, by Region, 2024
  • Figure 6 : Global Market Shares of Allergy Treatment, by Treatment Type, 2024
  • Figure 7 : Global Market Shares of Allergy Treatment, by Immunotherapy Type, 2024
  • Figure 8 : Global Market Shares of Allergy Treatment, by Region, 2024
  • Figure 9 : Global Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
  • Figure 10 : Global Market Shares for Food Allergens in Allergy Diagnostics and Treatment, by Region, 2024
  • Figure 11 : Global Market Shares for Inhaled Allergens in Allergy Diagnostics and Treatment, by Region, 2024
  • Figure 12 : Global Market Shares of Drug Allergens in Allergy Diagnostics and Treatment, by Region, 2024
  • Figure 13 : Global Market Shares of Other Allergens in Allergy Diagnostics and Treatment, by Region, 2024
  • Figure 14 : Global Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
  • Figure 15 : Global Market Shares of Prescription Drugs in Allergy Diagnostics and Treatment, by Region, 2024
  • Figure 16 : Global Market Shares of OTC Drugs in Allergy Diagnostics and Treatment, by Region, 2024
  • Figure 17 : Global Market Shares of Allergy Drugs, by Route of Administration, 2024
  • Figure 18 : Global Market Shares of Allergy Diagnostics and Treatment, by Region, 2024
  • Figure 19 : North American Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
  • Figure 20 : North American Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
  • Figure 21 : North American Market Shares of Allergy Treatment, by Treatment Type, 2024
  • Figure 22 : North American Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
  • Figure 23 : North American Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
  • Figure 24 : North American Market Shares of Allergy Diagnostics and Treatment, by Country, 2024
  • Figure 25 : European Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
  • Figure 26 : European Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
  • Figure 27 : European Market Shares of Allergy Treatment, by Treatment Type, 2024
  • Figure 28 : European Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
  • Figure 29 : European Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
  • Figure 30 : European Market Shares of Allergy Diagnostics and Treatment, by Country, 2024
  • Figure 31 : Asia-Pacific Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
  • Figure 32 : Asia-Pacific Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
  • Figure 33 : Asia-Pacific Market Shares of Allergy Treatment, by Treatment Type, 2024
  • Figure 34 : Asia-Pacific Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
  • Figure 35 : Asia-Pacific Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
  • Figure 36 : Asia-Pacific Market Shares of Allergy Diagnostics and Treatment, by Country, 2024
  • Figure 37 : Indian Market Shares of Allergy Treatment, by Treatment Type, 2024
  • Figure 38 : MEA Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
  • Figure 39 : MEA Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
  • Figure 40 : MEA Market Shares of Allergy Treatment, by Treatment Type, 2024
  • Figure 41 : MEA Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
  • Figure 42 : MEA Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
  • Figure 43 : MEA Market Shares of Allergy Diagnostics and Treatment, by Sub-region, 2024
  • Figure 44 : Middle East Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
  • Figure 45 : Middle East Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
  • Figure 46 : Middle East Market Shares of Allergy Treatment, by Treatment Type, 2024
  • Figure 47 : Middle East Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
  • Figure 48 : Middle East Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
  • Figure 49 : African Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
  • Figure 50 : African Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
  • Figure 51 : African Market Shares of Allergy Treatment, by Treatment Type, 2024
  • Figure 52 : African Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
  • Figure 53 : African Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
  • Figure 54 : South American Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
  • Figure 55 : South American Market Shares of Allergy Diagnostics, by Diagnostic Type, 2024
  • Figure 56 : South American Market Shares of Allergy Treatment, by Treatment Type, 2024
  • Figure 57 : South American Market Shares of Allergy Diagnostics and Treatment, by Allergen Type, 2024
  • Figure 58 : South American Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
  • Figure 59 : South American Market Shares of Allergy Diagnostics and Treatment, by Country, 2024
  • Figure 60 : Pillars of ESG
  • Figure 61 : Advantages of ESG for Companies
  • Figure 62 : AbbVie Inc.: Revenue Share, by Business Unit, FY 2024
  • Figure 63 : AbbVie Inc.: Revenue Share, by Country/Region, FY 2024
  • Figure 64 : ALK: Revenue Share, by Business Unit, FY 2024
  • Figure 65 : ALK: Revenue Share, by Country/Region, FY 2024
  • Figure 66 : Amgen Inc.: Revenue Share, by Business Unit, FY 2024
  • Figure 67 : Amgen Inc.: Revenue Share, by Country/Region, FY 2024
  • Figure 68 : AstraZeneca: Revenue Share, by Business Unit, FY 2024
  • Figure 69 : AstraZeneca: Revenue Share, by Region/Country, FY 2024
  • Figure 70 : Bayer AG: Revenue Share, by Business Unit, FY 2024
  • Figure 71 : Bayer AG: Revenue Share, by Country/Region, FY 2024
  • Figure 72 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
  • Figure 73 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
  • Figure 74 : GSK plc.: Revenue Share, by Business Unit, FY 2024
  • Figure 75 : GSK plc.: Revenue Share, by Country/Region, FY 2024
  • Figure 76 : Lilly: Revenue Share, by Business Unit, FY 2024
  • Figure 77 : Lilly: Revenue Share, by Country/Region, FY 2024
  • Figure 78 : Novartis AG: Revenue Share, by Business Unit, FY 2024
  • Figure 79 : Novartis AG: Revenue Share, by Country/Region, FY 2024
  • Figure 80 : Pfizer Inc.: Revenue Share, by Business Unit, FY 2024
  • Figure 81 : Pfizer Inc.: Revenue Share, by Country/Region, FY 2024
  • Figure 82 : Revvity: Revenue Share, by Business Unit, FY 2024
  • Figure 83 : Revvity: Revenue Share, by Country/Region, FY 2024
  • Figure 84 : Sanofi: Revenue Share, by Business Unit, FY 2024
  • Figure 85 : Sanofi: Revenue Share, by Country/Region, FY 2024
  • Figure 86 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
  • Figure 87 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024
  • Figure 88 : Viatris Inc.: Revenue Share, by Business Unit, FY 2024
  • Figure 89 : Viatris Inc.: Revenue Share, by Country/Region, FY 2024